TMCI Treace Medical Concepts Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TMCI

Price (delayed)

$4.51

Market cap

$293.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.92

Enterprise value

$349.83M

?
Relative Growth: Rel. Growth: 25
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 27
Highlights
The company's net income fell by 21% YoY but it rose by 2.5% QoQ
The EPS has declined by 16% year-on-year but it is up by 4.2% since the previous quarter
The equity has declined by 31% year-on-year and by 12% since the previous quarter
Treace Medical Concepts's quick ratio has decreased by 25% QoQ and by 25% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.treace.com
Peers: OFIX

Key stats

What are the main financial stats of TMCI

TMCI stock price

How has the Treace Medical Concepts stock price performed over time
Intraday
-1.74%
1 week
-1.1%
1 month
3.92%
1 year
-33.68%
YTD
84.08%
QTD
13.32%

Financial performance

How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$205.31M
Gross profit
$163.12M
Operating income
-$53.72M
Net income
-$59.52M
Gross margin
79.5%
Net margin
-29%
TMCI's net margin is down by 26% YoY
The company's net income fell by 21% YoY but it rose by 2.5% QoQ
The operating margin is down by 17% YoY but it is up by 2.6% QoQ
The operating income has contracted by 12% YoY but it has grown by 3.6% from the previous quarter

Price vs fundamentals

How does TMCI's price correlate with its fundamentals

Growth

What is Treace Medical Concepts's growth rate over time

Valuation

What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
4.32
P/S
1.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.7
The EPS has declined by 16% year-on-year but it is up by 4.2% since the previous quarter
TMCI's P/B is 52% above its last 4 quarters average of 2.9 but 44% below its 5-year quarterly average of 7.9
The equity has declined by 31% year-on-year and by 12% since the previous quarter
The P/S is 73% below the 5-year quarterly average of 5.4 but 32% above the last 4 quarters average of 1.1
TMCI's revenue is down by 4% YoY

Efficiency

How efficient is Treace Medical Concepts business performance
The return on equity has dropped by 58% year-on-year and by 7% since the previous quarter
Treace Medical Concepts's ROA has decreased by 35% YoY
Treace Medical Concepts's return on invested capital has decreased by 35% YoY
The return on sales has declined by 28% year-on-year but it is up by 2.2% since the previous quarter

Dividends

What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TMCI.

Financial health

How did Treace Medical Concepts financials performed over time
TMCI's total assets is 60% greater than its total liabilities
Treace Medical Concepts's quick ratio has decreased by 25% QoQ and by 25% YoY
Treace Medical Concepts's current ratio has decreased by 19% from the previous quarter and by 18% YoY
TMCI's debt is 2.1% higher than its equity
The debt to equity has grown by 48% YoY and by 13% from the previous quarter
The equity has declined by 31% year-on-year and by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.